Busey Bank’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-1,359
Closed -$241K 363
2021
Q2
$241K Sell
1,359
-253
-16% -$43.8K 0.01% 298
2021
Q1
$265K Sell
1,612
-145
-8% -$23.9K 0.01% 282
2020
Q4
$290K Sell
1,757
-887
-34% -$132K 0.02% 265
2020
Q3
$377K Sell
2,644
-135
-5% -$16.7K 0.02% 236
2020
Q2
$307K Sell
2,779
-302
-10% -$33.4K 0.02% 249
2020
Q1
$307K Sell
3,081
-77
-2% -$9.96K 0.02% 244
2019
Q4
$471K Sell
3,158
-34
-1% -$4.63K 0.03% 243
2019
Q3
$409K Buy
+3,192
New +$428K 0.03% 253

Other funds holding JAZZ

Busey Bank's JAZZ Position: Q3 2021 in Review

Busey Bank sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2021, closing a stake of 1,359 shares — an estimated $241K sold.

Busey Bank first reported a position in JAZZ in Q3 2019 and held it in 8 quarters. The position peaked at $471K in Q4 2019. 455 funds tracked by Wall St. Rank hold JAZZ as of Q3 2021.

  • Busey Bank reported no remaining Jazz Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Busey Bank sold 1,359 Jazz Pharmaceuticals shares in Q3 2021, an estimated $241K.
  • Busey Bank first reported a position in Jazz Pharmaceuticals in Q3 2019 and held it in 8 quarters.
  • Busey Bank's Jazz Pharmaceuticals position peaked at $471K in Q4 2019.
  • 455 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2021.

Based on Busey Bank's 13F filing for Q3 2021, filed 29 Oct 2021.